Inhaled corticosteroids with combination inhaled long-acting beta₂-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease

Abstract

Inhaled corticosteroids with combination inhaled long-acting beta 2 -agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.

Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA

“…For patients experiencing further exacerbations on dual bronchodilator therapy, outcomes may be improved with escalation to triple therapy (combining a LAMA, LABA, and inhaled corticosteroid [ICS]) [21][22][23][24]. However, available data on the optimal use of triple therapy and comparative outcomes for patients receiving dual or triple therapy are too limited for clear recommendations to be made [25][26][27].…”